NEU²

new drugs
against
neurological diseases

 
 

NEU² Partners: Baliopharm

Baliopharm GmbH

Karl-Heinz-Beckurts-Strasse 13
D-52428 Juelich

Baliopharm AG is a biotechnology company focusing on the development of novel therapeutics for the treatment of autoimmune diseases like rheumatoid arthritis, Crohn`s disease, psoriasis and multiple sclerosis, and for cancer. The company was founded in 2011 as a spin-off of Celonic AG, a service provider in the area of contract manufacturing and contract analysis operating since 1998. Since 2007, Celonic AG was also developing their own therapeutic proteins targeting cancer and immune-mediated diseases.

Baliopharm AG is focusing on the further preclinical and clinical development of these therapeutic proteins as well as on newly inlicensed compounds.

Baliopharm AG is located in Basel (Switzerland), with a subsidiary in Jülich (Baliopharm GmbH, Germany).

Ansprechpartner / Contact person:

Dr. Andreas Herrmann
Tel.: +41 61 2053-911
Fax: +41 61 2053-919
E-Mail: a.herrmann@balipharm.com

Kontakt / Contact:

Zentrale / Main:
Tel.: +49 2461 6210-855
Fax: +49 2461 6216-919
E-Mail: pharma@baliopharm.de
URL: www.baliopharm.com